Home > Financial Ratios > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for SAMRAT PHARMACHEM
Please provide your vote to see the results

SAMRAT PHARMACHEM Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -84.21-1.87172.3626.7998.19

What is the latest Core EBITDA Growth ratio of SAMRAT PHARMACHEM ?

The latest Core EBITDA Growth ratio of SAMRAT PHARMACHEM is -84.21 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-84.21
Mar2023-1.87
Mar2022172.36
Mar202126.79
Mar202098.19

How is Core EBITDA Growth of SAMRAT PHARMACHEM Trending?

Years Core EBITDA Growth % Change
Mar2024 -84.21
Negative
Mar2023 -1.87
Negative
Mar2022 172.36
543.37
Mar2021 26.79
-72.72
Mar2020 98.19 -

Other Financial Ratios of SAMRAT PHARMACHEM


Compare Core EBITDA Growth ratio of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹107.6 Cr 0% -1.9% -8.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,607.0 Cr -4.1% -2.1% -5.1% Stock Analytics
DIVIS LABORATORIES ₹170,148.0 Cr -2.8% -5.9% 29.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,285.0 Cr -4.1% 7.3% 14.3% Stock Analytics
CIPLA ₹121,103.0 Cr -3.7% 0.1% -2.9% Stock Analytics
DR REDDYS LABORATORIES ₹101,306.0 Cr -5.7% -6.1% -11.6% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

0%

-1.9%

-8.1%

SENSEX

0.2%

-2.7%

-0.9%


You may also like the below Video Courses